|
|
Start Date:Wednesday, September 14, 2022
Start Time:10:00 AM CDT (Chicago) / 5:00PM CET (Paris)
Duration:60 minutes
Abstract:
Bioprocessing 4.0 is embodied in the tools that increase efficiency and help companies keep an edge in today’s competitive biopharma landscape. In this webinar we review approaches that use digitization to give companies the flexibility needed to adjust process parameters quickly and easily while maintaining quality and reducing time and costs. We also look at technology that improves workflows in multiple ways, shortening process development cycles and accelerating time to market, increasing product titers and yields; and boosting product quality and uniformity.
Speakers
 Mohamed Noor, PhD Digitalization Manager National Institute for Bioprocessing Research and Training Mohamed Noor is currently the Digitalization Manager at Ireland’s National Institute for Bioprocessing Research and Training (NIBRT), where he is responsible for developing training curricula to integrate Industry 4.0 technologies in biopharma. Prior to joining NIBRT, he was a postdoctoral researcher at the University of Limerick, Ireland working with COOK Medical before moving to Janssen Sciences (J&J) and Regeneron Ireland. With a PhD in protein biochemistry and a Higher Diploma in data analytics, Mohamed is highly interested in the convergence of advances in data science and bioprocessing for optimized operations.  Laks Pernenkil, PhD Principal - Enterprise Operations Deloitte Consulting LLP Laks Pernenkil is a Partner in Deloitte Consulting’s Life Sciences practice. He leads Manufacturing and Quality Consulting Services in Life Sciences, as well as Deloitte’s MarginPLUS Margin and Performance Improvement Practice in Life Sciences.
He has over 15 years of technical, manufacturing, product and supply operations experience in Biopharma and Medtech sectors.
Laks has delivered large scale, complex manufacturing & supply chain operating model transformations, cost reduction engagements, and new product launches at several large Bio-Pharma and MedTech clients. In addition, his experience includes third-party logistics provider selection, channel strategy, CMO selection, performance improvement, operational excellence and market entry strategy.
Laks was a 2016 Ellen Gabriel Fellow and served to develop a Working Parent Retention Program for the Consulting Executive Committee. He leads the Supply Chain Operations Transformation Offering within Life Sciences Sector and co-leads Big Data Analytics for Life Sciences Manufacturing.
He has a Ph.D. in Chemical Engineering from MIT and an MBA from the MIT Sloan School of Management.  Rachel Arthur Editor BioPharma-Reporter Rachel is a journalist for BioPharma-Reporter, covering the latest stories and topics concerning the industry including vaccine development, cell and gene therapies, and M&A activity. Having worked for B2B publications for a number of years, her experience covers the food, beverage and pharmaceutical industries.
|
|
First Name
|
|
Last Name
|
|
Email Address
|
|
Company
|
|
Business Activity
|
|
Job Title
|
|
Job Seniority
|
|
Job Function
|
|
Company Employees
|
|
Country
|
|
|
Got a burning question about this topic? Send it to us using the box below and we will try to have it answered by our expert panelists. You are also welcome to ask questions on the live day
|
|
This Webinar is a free service provided to you by BioPharma-Reporter. The content of this service is sponsored by the partners named on this page. In order for you to receive this content, the above data is provided to these partners. Additional partners may join at a later stage and the full list of partners will be available on the day you access the webinar.
|
BioPharma-Reporter may use your contact data to keep you informed of its products and services by email or by phone. You can withdraw your marketing consent at any time by clicking the unsubscribe link in such email or by sending an email to dataprivacy@wrbm.com
More information on our processing can be found in our Privacy Notice. By submitting this form, you acknowledge that you have read and understand our Privacy Notice |
|
|
|
|
|
© 2022. All rights reserved.
|